Eisai Establishes New Manufacturing Subsidiary in United Kingdom.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Mar 5, 2007 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) Newswire) - Eisai Eisai (born 1141—died 1215) Japanese monk who introduced Rinzai Zen Buddhism to Japan. Originally a Tendai (Tiantai) monk, he visited China twice (1168, 1187) and returned to teach a strict meditational system based on the use of koan (riddles). He instructed Dogen. Co., Ltd. (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). : 4523) announced today that the Company established its pharmaceutical manufacturing subsidiary "Eisai Manufacturing Ltd."(EML EML - Extended ML. A language for formally specifying SML programs. ["Formal Program Development in Extended ML for the Working Programmer", D. Sannella, Proc 3rd BCS/FACS Workshop on Refinement", Springer 1990]. ) in Hatfield, United Kingdom. EML is owned by the Company's European European emanating from or pertaining to Europe. European bat lyssavirus see lyssavirus. European beech tree fagussylvaticus. European blastomycosis see cryptococcosis. regional headquarters, Eisai Europe Limited (Headquarters: London, President: Yutaka Tsuchiya). EML, which is the Company's first manufacturing facility in Europe, will function as the core base of quality assurance and supply chain management for the Eisai's European operations. Establishment of our own manufacturing base in Europe aims to enhance Eisai's global supply chain, ensuring the Company's commitment to a stable supply of safe and high-quality products across Europe. In addition, EML will be recruiting manufacturing/quality assurance experts by the targeted operation launch in FY 2008. Eisai has been rapidly expanding its European operations with the planned construction of the European Knowledge Center. Located in the pharmaceutical cluster to the north of London Hatfield, the Center will consolidate Eisai's all key value chain components in the entire region, including headquarters, discovery & clinical research, production, and marketing. Introduction of a new manufacturing subsidiary in Hatfield will lead to further progress in the Eisai's knowledge creation in manufacturing. Eisai is committed to satisfying the various medical needs and increasing the benefit to the patients and their families in Europe, through the stable supply of our high-quality products and information dissemination dissemination Medtalk The spread of a pernicious process–eg, CA, acute infection Oncology Metastasis, see there activities. Company Outline Company Name : Eisai Manufacturing Ltd. Establishment Date : March 1, 2007 Capital : 2 million pounds (approx. 500 million yen) Location : Hatfield, United Kingdom Operations : Manufacturing About Eisai Co., Ltd. Eisai Co., Ltd. (TSE: 4523; ADR ADR - Astra Digital Radio : ESALY) is a research-based human health care company that discovers, develops and markets products in more than 30 countries. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system. Eisai employs more than 8,000 people worldwide. For more information, please visit http://www.eisai.co.jp. Source: Eisai Co., Ltd. Contact: Corporate Communications Department Eisai Co., Ltd. TEL: +81-3-3817-5036 Copyright [c] 2007 JCN Newswire. All rights reserved. A division of Japan Corporate News Network K.K. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion